Chronic Kidney Disease Market - By Treatment: Dialysis, Kidney Transplant, Drug Therapy; By Drug Type: ACE Inhibitors, Angiotensin Receptor Blockers, Diuretics, Phosphate Binders; By End-User: Hospitals, Dialysis Centers, Clinics; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
1 | Market Overview
The global market for chronic kidney disease (CKD) is experiencing significant growth, driven by the increasing rates of diabetes, hypertension, and aging populations. CKD is a progressive disease marked by the gradual decline of kidney function, which can lead to complications such as cardiovascular disease and end-stage renal disease (ESRD). Growing awareness, advances in diagnostic techniques, and the expansion of dialysis and transplant services are boosting demand.
Pharmaceutical innovation targeting CKD progression and its complications, along with government-led initiatives for early screening, further support market growth.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
63.2 |
Historical benchmark |
|
2024 |
86.5 |
Five-year CAGR 6.5% |
|
2031 |
142.8 |
Seven-year CAGR 7.4% |
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
|
Company |
Estimated Market Share |
Key Products |
|
Baxter International |
20% |
Dialysis equipment and solutions |
|
Fresenius Medical Care |
18% |
Hemodialysis systems, peritoneal dialysis |
|
AbbVie |
14% |
CKD therapeutics (e.g., for anemia) |
|
AstraZeneca |
12% |
CKD medications including SGLT2 inhibitors |
|
Others |
36% |
Generic and specialty providers |
6 | Market Segmentation
By Treatment Type:
By Stage:
By End User:
By Region:
7 | Strategic Outlook
The CKD market is expected to continue expanding with earlier detection, advances in tele-nephrology, and personalised medicine approaches. Collaborations between pharmaceutical companies, device manufacturers, and healthcare systems will be crucial for improving patient outcomes.
Need help?
Chat with our team in a minute.